Cardiovascular Effects of Propofol as an Induction Agent in Kidney Recipients.
10.4097/kjae.1995.29.2.192
- Author:
Eun Hwan CHOI
1
;
Soon Ho NAM
;
Yang Sik SHIN
;
Jong Rae KIM
Author Information
1. Department of Anesthesiology, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Cardiovascular effect;
Propofol;
Renal transplantation
- MeSH:
Blood Pressure;
Heart Rate;
Humans;
Intubation;
Intubation, Intratracheal;
Kidney Transplantation;
Kidney*;
Lidocaine;
Propofol*;
Thiopental
- From:Korean Journal of Anesthesiology
1995;29(2):192-197
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
A need has been recognized for a safe and effective induction for patients undergoing elective renal transplantations. We have evaluated the effect of propofol (injection rate; 50 mg/min, average dosage; 2.28+/-0.08 mg/kg, n=10) on a cardiovascular stability compared with that of thiopental (injection rate; 100 mg/min, average dosage; 5.22+/-0.18 mg/kg, n=10) as an induction agent. Blood pressure and heart rate as cardiovascular parameters were checked before induction(control), one, two, three minutes after induction, before and after orotracheal spray of lidocaine, and immediately, one and two minutes after endotracheal intubation. The results were as follows: 1) There were no significant cardiovascular changes in the propofol group during the whole induction period. 2) In the thiopental group, diastolic blood pressures checked just after intubation, which were 120.20+/-7.79 mmHg, were significantly higher than those of one or two minutes after induction, which were 86.30+/-4.36, 88.40+/-3.85 mmHg, respectively. The above results suggest that intravenous propofol (2.0~2.5 mg/kg) is a safe and effective induction agent for renal recipients.
